An AI-enabled software tool that predicts the development of dangerous brain swelling after a stroke has received FDA Breakthrough Device designation. Beacon-Neuro.AI Inc., a Washington University in St. Louis startup, has gained access to technology underpinning the tool, which was developed by researchers at WashU Medicine.
If you liked the article, do not forget to share it with your friends. Follow us on Google News too, click on the star and choose us from your favorites.
If you want to read more Like this articles, you can visit our Science category.
